The G-I-N 2016 Scientific Committee is honored to announce the following list of international speakers.
Professor Mark Baker is the Director of the Centre for Clinical Practice at NICE where he is responsible for the Clinical Guidelines programme and advice on the use of medicines. He joined the staff of NICE in 2009 as Consultant Clinical Adviser to the Internal Guidelines Team and took up his current Director post in April 2012.
Mark qualified in Medicine in 1973 and has postgraduate qualifications in general medicine and public health medicine.
In a wide ranging career in the NHS, he has held the Director or Chief Executive posts at every level of the service. For much of the last twenty years he has been extensively involved in the development of NICE cancer guidance including the Cancer Service Guidance programme, as chair of the guideline development groups on prostate cancer and lung cancer and in his current post. He has also held regional and national leadership positions in cancer services development.
In his academic career, he has also held professorial appointments at the Universities of Bradford, Leeds and York.
He is a Fellow of the Royal College of Physicians and, formerly, a Fitness to Practice Panellist for the General Medical Council.
Professor Baker is presenting in Plenary Panel 3 - Innovative Efficiencies in Guideline Development, Maintenance, and Adaptation: A Look to the Future, on Thursday, 29 September 2016 at 2:00 pm.
Prof. Dr. med. Anke Bramesfeld, MD, MPH, registered in Psychiatry and Psychotherapy, associated Professor in Public Health and Public Mental Health of Hannover Medical School. As current employed as scientific officer at the Joint Research Centre (JRC) in Ispra, Italy, the European Commission's in-house science service that is developing a voluntary European Quality Assurance Scheme for Breast Cancer Services. 2012-2015 AQUA-Institute for applied quality improvement and research in health care GmbH, Göttingen Germany; at that time commissioned with development and implementation of the mandatory quality assurance programme of the German health care system. Before that, health services and system research with a focus on mental health at Hannover Medical School and Leipzig University. 2009-2010 Seconded National Expert to the European Commission's Directorate General for Health and Consumers, Luxembourg.
Dr. Bramesfeld is presenting in Plenary Panel 1 - Translating Guidelines to Performance Measures in an Era of Accountability on Wednesday, 28 September 2016 at 2:30 pm.
Dr. Kate Goodrich joined the Centers for Medicare and Medicaid Services in September of 2011 where she serves as Director of the Center for Clinical Standards and Quality (CCSQ). This Center is responsible for over 20 quality measurement and value-based purchasing programs, implementation of the new Merit-based Incentive Payment System and the Improving Medicare Post-Acute Care Transformation Act, quality improvement programs in all 50 states, clinical standards and survey and certification of all providers across the nation, and all coverage decisions for treatments and services for CMS. The Center budget exceeds $1.3 billion annually.
Previously, Dr. Goodrich served as the Director of the Quality Measurement and Value-based Incentives Group in CCSQ where she oversaw the implementation of over 20 quality, value-based purchasing and public reporting programs across multiple settings. She also co-lead an HHS-wide group to align quality measures across programs, and more recently has worked with numerous private payers to align measures across the public and private sectors. From 2010 – 2011 she served as a Medical Officer in the office of the Assistant Secretary for Planning and Evaluation (ASPE) at DHHS where she managed a portfolio of work on comparative effectiveness research and quality measurement and improvement.
Dr. Goodrich is a graduate of the Robert Wood Johnson Clinical Scholars Program at Yale University where she received training in health services research and health policy from 2008-2010. From 1998 to 2008, Dr. Goodrich was on faculty at the George Washington University Medical Center (GWUMC) and served as Division Director for Hospital Medicine from 2005-2008 and was chair of the Institutional Review Board from 2004-2008. She went to medical school at Louisiana State University in Shreveport, LA, and completed her internal medicine residency and chief medical resident year at GWUMC. She continues to practice clinical medicine as a hospitalist and Associate Professor of Medicine at GWUMC.
Dr. Goodrich is presenting in Plenary Panel 1 - Translating Guidelines to Performance Measures in an Era of Accountability on Wednesday, 28 September 2016 at 2:30 pm.
Dr. Martin Kohn is Chief Medical Scientist at Sentrian, which creates predictive analytic systems integrating home monitoring with longitudinal health data for patients with complex chronic diseases. The Sentrian system identifies patients that are likely to deteriorate to allow the care providers enough time to intervene to mitigate or prevent the deterioration, reducing avoidable hospitalizations.
Dr. Kohn is a board-certified emergency physician with over 30 years of practice and management experience. He is an alumnus of MIT, Harvard Medical School and NYU. He has been a healthcare executive, educator and congressional health policy advisor. Dr. Kohn is board certified in Clinical Informatics, has published on clinical, technical and management subjects and speaks frequently on the role of “Big Data” in the transformation of healthcare. Previously, he was the Chief Medical Scientist for Care Delivery Systems in IBM Research developing analytic tools for healthcare, including the use of the Watson supercomputer.
Dr. Kohn is presenting in Plenary Panel 2 - Incorporating Alternative Forms of Evidence into Guidelines, on Thursday, 29 September 2016 at 8:30 am.
Dr. Kevin Larsen is a senior Medical Officer at the Centers for Medicare and Medicaid Services. He leads the CMS lean transformation and advises on health IT policy and care transformation. He previously served for 4 years as the Medical Director of Meaningful Use at the Office of the National Coordinator for Health IT, where he lead ONCs work on quality policy, measurement and improvement, including clinical decision support and registries. Prior to working for the federal government he was Chief Medical Informatics Officer and Associate Medical Director at Hennepin County Medical Center in Minneapolis, Minnesota. He is also an Associate Professor of Medicine at the University of Minnesota. His research includes health care financing for people living in poverty, computer systems to support clinical decision making, and health literacy. In Minneapolis he was also the Medical Director for the Center for Urban Health, a hospital, community collaboration to eliminate health disparities.
Dr. Larsen is presenting in Plenary Panel 4 - Leveraging Technology to Promote Guideline Implementation, on Friday, 30 September 2016 at 10:30 am.
Dr. Fergus Macbeth recently retired from active clinical working as an oncologist. He also worked for the National Institute for Health and Care Excellence (NICE) for almost 10 years, first as Director of the National Collaborating Centre for Cancer, developing cancer guidelines for NICE and latterly, until his retirement, as Director for the Centre for Clinical Practice, responsible for NICE’s wider clinical guidelines and quality standards programmes. He served on the Board of GIN from 2011 to 2014. He still works part time as Mentor to NICE Fellows and Scholars and has recently chaired two guideline development groups. He has been Coordinating Editor of the Cochrane Lung Cancer Review Group for 5 years and is also joint Funding Arbiter for Cochrane, assessing issues of conflicts of interest across the organisation. He is currently Associate Director of the Wales Cancer Trials Unit, Cardiff and Honorary Professor at Cardiff University. He teaches for the UK Cochrane Centre and the Collaboration for Evidence Based Healthcare in Africa. He has published widely on lung cancer and on guideline related topics.
Dr. Macbeth is presenting in the Opening Plenary – Individualising Guidance in an Era of Personalised Medicine on Wednesday, 28 September 2016 at 9:00 am.
Dr. Lawrence Mbuagbaw is a public health physician, research methodologist and biostatistician. He works as assistant professor in the Department of Clinical Epidemiology and Biostatistics, McMaster University. His research interests are mother and child health, human immunodeficiency virus (HIV) care, health systems research, mHealth and health research methodology – with a focus on enhancing biostatistics and epidemiological techniques to improve health outcomes using pragmatic knowledge translation designs. He has authored over 80 peer reviewed publication with more that 10 systematic reviews and meta-analyses. He is an editor for the Cochrane Infectious Diseases Group and a member of the G-I-N Africa Steering Committee.
Dr. Mbuagbaw is presenting in Plenary Panel 4 - Leveraging Technology to Promote Guideline Implementation, on Friday, 30 September 2016 at 10:30 am.
Professor Jane Noyes is Professor of Health and Social Services Research and Child Health. She moved to Bangor University in 2005, having previously worked at Manchester, York, Keele and Salford Universities, and the National Heart and Lung Institute at the University of London.
Jane is interested in methodology, including: complex intervention development and evaluation, and qualitative and mixed method systematic review methodology. She is a Convenor of the Cochrane Qualitative and Implementation Methods Group and Co-Chair of the Cochrane Methods Executive. She has been actively involved in developing the methods for qualitative and mixed-method synthesis and incorporation of qualitative evidence in guidelines. Jane is currently working a WHO methodologist on a complex WHO guideline where few trials exist.
Jane also specialises in child health and social care research and cost consequences. Her research interests include acute care, complex care, long-term conditions and self-management, transition to adult services, young adulthood with disability, end of life care, and sibling and family care. She has growing interests in international maternal child health in lower and middle income countries, and reverse innovation. Jane is Editor of the Journal of Advanced Nursing. She is an enthusiastic supporter of leading children’s charities in various high profile roles.
Dr. Noyes is presenting in Plenary Panel 2 - Incorporating Alternative Forms of Evidence into Guidelines, on Thursday, 29 September 2016 at 8:30 am.
Douglas K. Owens, MD, MS, is the Henry J. Kaiser, Jr., Professor at Stanford University, where he is a professor of medicine, and, by courtesy, of health research and policy, and of management science and engineering. He is director of the Center for Health Policy in the Freeman Spogli Institute for International Studies and director of the Center for Primary Care and Outcomes Research (PCOR) in the Department of Medicine. He is a general internist and associate director of the Center for Innovation to Implementation at the Veterans Affairs Palo Alto Health Care System. His research focuses on technology assessment, cost-effectiveness analysis, evidence synthesis, and methods for clinical guideline development. Dr. Owens chaired the Clinical Guidelines Committee of the American College of Physicians. He also served on the United States Preventive Services Task Force (USPSTF), which creates national guidelines on prevention services. Recently, he has helped lead the development of national U.S. guidelines on screening for HIV, hepatitis C, hepatitis B, lung cancer, colorectal cancer, breast cancer, and use of aspirin and statins to prevent cardiovascular disease.
Dr. Owens is presenting in the Opening Plenary – Individualising Guidance in an Era of Personalised Medicine on Wednesday, 28 September 2016 at 9:00 am.
Paul G. Shekelle, MD, MPH, PhD In addition to currently serving as a Staff Physician at the West Los Angeles Veterans Affairs Medical Center, Dr. Shekelle directs the VA Evidence Synthesis Program there. Dr. Shekelle also has served as the Director of the Southern California Evidence-based Practice Center for the RAND Corporation since 1997. He is a Professor of Medicine at the University of California, Los Angeles (UCLA) School of Medicine. He is widely recognized in the field of guidelines, quality measurement, and evidence-based medicine. He is the immediate past-chair of the Clinical Guidelines Committee of the American College of Physicians.
After receiving a B.S. in both Biology and Chemistry at the University of Illinois, Dr. Shekelle earned his MD in 1982 from Duke University. He completed his internship, residency, and fellowship at UCLA, where he also obtained his MPH in 1989 and his PhD in 1993.
Dr. Shekelle is presenting in Plenary Panel 3 - Innovative Efficiencies in Guideline Development, Maintenance, and Adaptation: A Look to the Future, on Thursday, 29 September 2016 at 2:00 pm.
Per Olav Vandvik, MD, PhD, is associate professor at the Department of Health Management and Health Economics, University of Oslo, Norway. He is also researcher at the Norwegian Knowledge Centre for the Health Services in Oslo and acting consultant at the Department of Medicine, Lovisenberg Diaconal Hospital.
Dr.Vandvik spends most of his time heading a team dedicated to develop innovative solutions for providing clinicians and patients with trustworthy evidence summaries, guidelines and decision aids at the point of care (www.magicproject.org). More lately his work includes wide international collaboration to develop a Digital and Trustworthy Evidence Ecosystem. Dr.Vandvik is a G-I-N Board of Trustees member and also a recognized teacher in evidence-based medicine and guideline methodology for clinicians and decision-makers in health care.
Dr. Vandvik is presenting in Plenary Panel 4 - Leveraging Technology to Promote Guideline Implementation, on Friday, 30 September 2016 at 10:30 am.
Lelis Bauza Vernon, BA is chair of the Parent Advisory Council for the Neonatal Intensive Care Unit (NICU) at Baptist Children’s Hospital in Miami, Florida, U.S. Through the Council, she has worked for the past 8 years to create, grow, and coordinate educational and programmatic activities from a parent’s perspective to promote family-centered care in the NICU. She also actively participates and collaborates in specific study groups, including a NIH-funded study by Dr. Jochen Profit, MD, MPH at Stanford University, Division of Neonatal Medicine - Perinatal Systems Research to assess disparities in the quality of care in NICUs, she is currently serving as Faculty member in the Micro-premature Care Team at the Vermont Oxford Network, an exemplary organization that collects and feeds back NICUs clinical data from more than 90% of VLBW babies in the United States, in this role she helps guide quality improvement efforts and extract systematic learning for NICUs around the US. She is also a US Family representative in the Advisory Council for the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) Federation International. In 2016, Lelis joined the American College of Physician’s Public Involvement Program as a public jury member for its Clinical Guidelines Committee.
Lelis’ commitment to advocating the family and patient voice is driven by her experiences as the mother of premature twins and the wife of a spinal cord injury patient. Lelis is originally from Argentina, studied in England, and has lived in Brazil, Venezuela, and the United States.
Ms. Lelis Vernon is presenting in the Opening Plenary – Individualising Guidance in an Era of Personalised Medicine on Wednesday, 28 September 2016 at 9:00 am.
Dr. Diane Watson was the inaugural Chief Executive Officer of the National Health Performance Authority - Australia’s national organisation established to monitor, and report on, the comparable performance of health care organisations and the health system at the local level. This information is available on the MyHospitals and MyHealthyCommunities websites.
In 2015-16 she was co-chair of the Independent Hospital Pricing Authority and Australian Commission for Safety and Quality in Healthcare’s committee to explore the feasibility of implementing best practice pricing nationally, in tandem with quality and safety performance information in order to drive quality improvement.
Prior to her appointment at the Performance Authority, Diane was the inaugural Chief Executive Officer of the NSW Bureau of Health Information. Prior to working in Australia, she held management and senior scientist positions in Canada and the USA. In 2005, Diane was a Harkness Fellow in the International Health Policy Program with the Commonwealth Fund.
Dr. Watson is presenting in Plenary Panel 1 - Translating Guidelines to Performance Measures in an Era of Accountability on Wednesday, 28 September 2016 at 2:30 pm.
Naohito Yamaguchi, MD, PhD, graduated from Keio University School of Medicine, Japan, in 1978, and started his career as researcher in epidemiology and public health. Currently, he is professor and chair of Department of Public Health, Tokyo Women’s Medical University School of Medicine.
Prof. Yamaguchi has been serving as the Director of Minds Guideline Center, Japan, since its foundation in 2002. Minds Guideline Center was established by the Japan Council for Quality Health Care, a non-profit third party organization, with a full financial support by the Ministry of Health, Labor and Welfare, Japan, to promote evidence-based clinical practice in Japan. Minds Guideline Center functions as the clearinghouse of clinical practice guidelines developed in Japan; its website disseminates more than 160 clinical practice guidelines. Minds Guideline Center also has a wide range of guideline-related activities; it supports guideline developers by providing methodological guidance; it also supports hospitals and clinics for efficient guideline implementation; and it supports patients and practitioners for their utilization of clinical practice guidelines in share decision making.
Prof. Yamaguchi is currently serving as the chair of G-I-N Asia, which was founded in 2015.
Prof. Yamaguchi is presenting in Plenary Panel 3 - Innovative Efficiencies in Guideline Development, Maintenance, and Adaptation: A Look to the Future, on Thursday, 29 September 2016 at 2:30 pm.
Teun Zuiderent-Jerak, PhD, is LiU Research Fellow and Senior Lecturer in Science and Technology Studies at the Department of Thematic Studies – Technology and Social Change of Linköping University, Sweden. His research focuses on standardization and quality improvement practices in health care and with a particular focus on medical knowledge. He co-chairs the G-I-N Working Group on Appraising and Including Different Knowledge (AID Knowledge). His publications can be found in the British Medical Journal, BMJ Quality and Safety, BMC Medical Research Methodology, Health Care Analysis, Health Economics, Policy and Law, Health Expectations, Health Policy, Human-Computer Interaction, Science as Culture, Science, Technology, and Human Values, Social Science & Medicine, and Social Studies of Science. His book Situated Intervention; Sociological Experiments in Health Care was published in 2015 by the MIT Press.
Mr. Zuiderent-Jerak is presenting in Plenary Panel 2 - Incorporating Alternative Forms of Evidence into Guidelines, on Thursday, 29 September 2016 at 8:30 am.